Neutrophil-to-lymphocyte ratio in combination with PD-L1 or lactate dehydrogenase as biomarkers for high PD-L1 non-small cell lung cancer treated with first-line pembrolizumab

JOURNAL ARTICLE published August 2020 in Translational Lung Cancer Research

Authors: Giuseppe Luigi Banna | Diego Signorelli | Giulio Metro | Domenico Galetta | Alessandro De Toma | Ornella Cantale | Marco Banini | Alex Friedlaender | Pamela Pizzutillo | Marina Chiara Garassino | Alfredo Addeo